02258nam 2200553 450 991079228700332120230803024232.01-78084-315-1(CKB)2560000000152106(EBL)1179633(SSID)ssj0001526194(PQKBManifestationID)11887088(PQKBTitleCode)TC0001526194(PQKBWorkID)11504457(PQKB)10540034(MiAaPQ)EBC1179633(Au-PeEL)EBL1179633(OCoLC)877766976(EXLCZ)99256000000015210620220517d2013 uy 0engur|n|---|||||txtccrClostridium difficile new challenges for an old foe /editors, Glenn S. Tillotson, Karl Weiss1st ed.London, England :Future Medicine Ltd.,[2013]©20131 online resource (157 p.)Description based upon print version of record.1-78084-317-8 Title page; Copyright page; Contents; Foreword. Clostridium difficile: new challenges for an old foe; 1. Clostridium difficile infection: a global threat; 2. Pathogenicity mechanisms of Clostridium difficile; 3. Immunology and Clostridium difficile; 4. The microbiome and Clostridium difficile infection; 5. Economic burden of Clostridium difficile infection; 6. Laboratory diagnosis of Clostridium difficile infection; 7. Conventional therapeutics for Clostridium difficile infection; 8. Infection control issues in Clostridium difficile9. Future and alternative approaches to managing Clostridium difficile infectionEpilogue. Recent advances with Clostridium difficile; IndexClostridium Difficile: New Challenges for an Old FoeClostridium difficileClostridium diseasesClostridium difficile.Clostridium diseases.616.3447Weiss KarlTillotson Glenn S.MiAaPQMiAaPQMiAaPQBOOK9910792287003321Clostridium difficile2650510UNINA